Metizoline
From Wikipedia, the free encyclopedia
 |
|
|
Metizoline
|
|
| Systematic (IUPAC) name | |
| 2-[(2-methyl-1-benzothiophen-3-yl)methyl]-4,5-dihydro-1H-imidazole | |
| Identifiers | |
| CAS number | ? |
| ATC code | R01 |
| PubChem | |
| Chemical data | |
| Formula | C13H14N2S |
| Mol. mass | 230.329 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Metizoline is a nasal preparation.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
|
|||||||||||||||||
